Silvestro Orlando, Ricciardi Luisa, Catalano Antonino, Vicario Carmelo Mario, Tomaiuolo Francesco, Pioggia Giovanni, Squadrito Giovanni, Schwarz Peter, Gangemi Sebastiano, Martino Gabriella
Department of Health Sciences, University Magna Graecia of Catanzaro, Catanzaro, Italy.
Department of Clinical and Experimental Medicine, University Hospital of Messina, Messina, Italy.
Front Psychol. 2023 Aug 7;14:1221648. doi: 10.3389/fpsyg.2023.1221648. eCollection 2023.
Growing evidence from scientific research elucidates the important role of alexithymia in chronic immune diseases. This Review aims to explore the presence of alexithymia in patients affected by asthma and clarify its associations with other involved psychological and physical factors. In January 2023, according to PRISMA guidelines, a systematic search using PubMed and Scopus was conducted. Twenty-six studies were eligible based on inclusion criteria. Alexithymia was significantly present in asthma patients, with most studies reporting a higher prevalence (from 9 to 62.8%) than in control groups (approximately 10%). The coexistence of asthma and alexithymia was associated with a worse quality of life, psychiatric comorbidity, poor symptom control, and difficulty in recognizing exacerbations of the disease. These results suggest that alexithymia can negatively impact the management of asthma. For this reason, we recommend an accuracy assessment in clinical settings and the implementation of psychological interventions to promote the emotional and physical wellbeing of asthmatic patients.
科学研究中越来越多的证据阐明了述情障碍在慢性免疫疾病中的重要作用。本综述旨在探讨哮喘患者中述情障碍的存在情况，并阐明其与其他相关心理和生理因素的关联。2023年1月，根据PRISMA指南，使用PubMed和Scopus进行了系统检索。基于纳入标准，有26项研究符合要求。哮喘患者中显著存在述情障碍，大多数研究报告其患病率（9%至62.8%）高于对照组（约10%）。哮喘和述情障碍并存与生活质量较差、精神疾病共病、症状控制不佳以及难以识别疾病加重有关。这些结果表明，述情障碍会对哮喘的管理产生负面影响。因此，我们建议在临床环境中进行准确评估，并实施心理干预，以促进哮喘患者的情绪和身体健康。
